You are on page 1of 46

Ischaemia of Lower Limbs

By

Dr. Shampile
Terminology
• Acute: <14 days
• Acute on chronic: worsening in <14 days
• Chronic: stable for >14 days
• Incomplete: no limb threat
• Complete: limb threatened
• Irreversible: limb non viable
Definition
• peripheral vascular disease refers to the
obstruction or deterioration of arteries other
than those supplying the heart and within the
brain.
Aetiology-ALI
Embolism- 90% from heart, 9% from great
vessels, 1% other.
• Left atrium in patients in atrial fibrillation
• Mural thrombus after myocardial infarct
• Prosthetic and diseased heart valves
• Aneurysm or atheromatous stenosis
• Tumour, foreign body
Aetiology-cont’d
Thrombosis; Atherosclerosis, aneurysm, graft stenosis, low flow,
e.g. hypovolaemia, thrombotic states.
Other
• Trauma ( general or operative)
• Arteritis,
• Congenital anomalies
• Dissecting aneurysm
• Raynaud's Syndrome
• Metabolic (DM)
• Drugs e.g. Acute ischaemia due to intra-arterial temazepam
injection
Pathophysiology-ALI
• Sudden interruption of blood supply.
• Emboli tend to lodge at sites of vessel
bifurcation.
• There are two phases of cell injury: ischaemic
injury as tissues are deprived of blood supply
and reperfusion injury if blood flow is
restored
Clinical features of limb ischaemia

• Symptoms and signs depend on the site of


occlusion, duration of ischaemia and degree of
collateral circulation.
• Embolus more likely if severe, sudden onset and
potential source identifiable, e.g. atrial
fibrillation.
• Thrombosis usually if less severe (collaterals
present), history of claudication
Acute arterial occlusion
• Pain (absent in incomplete ischemia)
• Pallor (present in chronic ischemia)
• Pulselessness (present in chronic ischemia)
• Perishing cold (unreliable)
• Paresthesia (leading to anaesthesia)
• Paralysis (contrasts with venous
occlusion when muscle function is not
affected)
• Ischaemia beyond 6 hours is usually
irreversible and results in limb loss.
• No history of claudication
EXAMINATION
• Limb is pale with absent pulses; capillary
return is slow.
• After several hours, there is venous
stagnation.
• Altered sensation, and if ischaemia is severe,
paraesthesia with muscle paralysis
INVESTIGATIONS
• Bloods: FBC, U&Es, coagulation profile,
thrombophilia screen.
• Imaging: CXR, Doppler or duplex scanning of
blood flow, arteriography to demonstrate the
site of occlusion and plan intervention if limb
viable.
• ECG: Looking for atrial fibrillation.
Management
Diagnois
• Is this ischaemia ?
• Is this an embolism or thrombosis ? clinical features
include:
 Rapidity of onset of symptoms
 Features of pre-existing chronic arterial disease
 Potential source of embolus
 State of pedal pulses in contralateral leg
• Is this limb viable ?
MANAGEMENT
• Immediate: ABCs, analgesia, heparin
anticoagulation to prevent thrombus
propagation.
• Treat associated cardiac disease
• Surgical: Revascularisation within 6 hours in
order to salvage limb. Operative risk is often
high due to underlying heart disease.
Postoperative anticoagulation is essential
MANAGEMENT
Treatment options are:
• Embolic disease - embolectomy or intra-
arterial thrombolysis
• Thrombotic disease - intra-arterial
thrombolysis / angioplasty or bypass surgery
• Amputation ; if non viable limb
MANAGEMENT
Emergency embolectomy
• Can be performed under either general or local
anaesthesia
• Display and control arteries with slings
• Transverse artereotomy performed over common
femoral artery
• Fogarty balloon embolectomy catheters used to retrieve
thrombus
• If embolectomy fails - ontable angiogram and consider
Bypass graft or intraoperative thrombolysis
MANAGEMENT
• If acute or chronic thrombosis: The limb may
remain viable for a longer time due to
collateral formation, and percutaneous
intervention is an option, e.g. aspiration,
intraarterial thrombolysis with local infusion
of, e.g., t-PA, and angioplasty of underlying
stenoses.
MANAGEMENT
Intra-arterial thrombolysis
• Arteriogram and catheter advanced into thrombus
• Streptokinase 5000u/hr + heparin 250u/hr
• Alternative thrombolytic agents include Urokinase
or tissue plasminogen activator (tPA)
• Repeat arteriogram at 6 -12 hours
• Advance catheter and continue thrombolysis for
48 hours or until clot lysis
MANAGEMENT
• Angioplasty of chronic arterial stenosis may be
necessary
• Success 60-70% but needs careful case selection
• Not suitable if severe neuro-sensory deficit
• Thrombolysis can be accelerated by
 Pulse spray through multiple side hole catheter
 Aspiration thrombectomy - debulking thrombus
aspiration
 High dose over shorter time
MANAGEMENT
• If thrombosis but the limb is not likely to
remain viable for 12–24 hours necessary for
this procedure: Urgent reconstructive surgery
is required,
• if technically possible with autogenous
(saphenous vein) or synthetic (e.g. PTFE or
Dacron) bypass grafting.
• If risk of compartment syndrome, fasciotomy is
required.
Vascular Trauma of the Extremity
• Often the extremities are placed at the
bottom of the ‘‘to-do’’ list in patients with life-
threatening multisystem trauma, only to find
an ischemic limb hours later.
• Therefore, a high index of suspicion is
warranted in patients with extremity
fracture/dislocations
Vascular Trauma of the Extremity
• Blunt trauma results in a stretch injury and
subsequent occlusion of the artery at the level
of the associated fracture or joint dislocation.
• Penetrating wounds can produce either vessel
transection or a pseudoaneurysm
• Angiography, to discern between vessel spasm
and overt injury, can be performed in the
angiography suite or in the OR.
COMPLICATIONS
• From disease: Gangrene, limb loss, death.

• From intra-arterial thrombolysis: Mortality


(1–2%), CVA, major haemorrhage
• Post-treatment: Reperfusion syndrome,
compartment syndrome, rhabdomyolysis,
rethrombosis.
PROGNOSIS
• Risk of limb loss is up to 30%; mortality 10%,
with major mortality factor underlying cardiac
disease.
Chronic Arterial Insufficiency
• Asymptomatic to gangrenous tissue loss
• Intermittent claudication
• Rest pain
• Dependent rubor
• Ulceration
• Gangrene
• Arterial pulsation diminished or absent
• Arterial bruit
• Slow capillary refilling
Chronic vascular insufficiency
• Claudication: crampy aching pain in the calf
muscles appearing with fixed level of exercise
(claudication distance) and relieving promptly
(2-3 mins) on rest
– Boyds 1: pain- walk- relief
– Boyds 2: pain- walk- no relief
– Boyds 3: pain- stop- relief
– Boyds 4: rest pain
Chronic vascular insufficiency-cont’d
• Rest pain: cry of the dying nerves; some relief
by “gravity aid”
– A limb with rest pain may appear red due to
accumulation of vasodilator metabolites: sunset
foot sign/ dependent rubor
• Ulceration: arterial ulcers
• Pregangrene: any 2 (rest pain, edema,
hyperaesthesia, colour changes, ulceration)
• Gangrene
 Sabiston’s 19th ed
Ankle Brachial Pressure Index (ABPI)
• It is cornerstone of diagnosis
• ratio of systolic pressure at the ankle to that in
the arm.
• The highest pressure in the dorsalis pedis,
posterior tibial or peroneal artery serves as the
numerator, with the highest brachial systolic
pressure being the denominator
• Supine position, proper cuff size
• >1.3: Arteriosclerosis
ABI-cont’d
• Resting ABPI is normally about 1.0;
• values below 0.9 indicate some degree of
arterial obstruction (claudication),
• less than 0.5 suggests rest pain and
• less than 0.3 indicates imminent necrosis.
• Even normal values may present with
intermittent claudication
Site of blockage Clinical features
Aortoiliac Leriche syndrome, buttock-
thigh-calf claudication
Common femoral Thigh & calf claudication
Superficial femoral Calf
Popliteal Calf
Crural Calf
Atherosclerosis vs Buerger’s
Atherosclerosis Buerger’s (OLIN criteria-2000)
• Old age • <45 yrs
• Hypercholesterolemia • Tobacco use (chewing/ smoking)
• Smoking (4x) • Distal extremity ischemia
• Diabetes mellitus (3-5x) • Exclusion of autoimmune
disease, hypercoagulability and
• Hypertension
DM
• Pvs history of thromboembolic • Exclusion of proximal source of
phenomena (stroke/ TIA/ emboli
amaurois fugax, DVT etc.)
• Consistent imaging findings
• Large & medium sized elastic
• Medium to small sized vessels
& muscular vessels
CT angiography
Atherosclerosis Buerger’s
Other Diseases
• Takayasu arteritis: pulseless disease of asian young
females
• Raynaud phenomenon: pallor followed by cyanosis &
rubor
• Raynaud’s syndrome: peripheral arterial
manifestation of a collagen disease, such as systemic
lupus erythematosus or rheumatoid arthritis or
vibration white finger.
• Raynaud disease: Raynaud phenomenon in a young
female without any other cause
Pathogenesis of Atherosclerosis
Pathogenesis of Buerger’s Disease
• Cellular, segmental, occlusive inflammatory
thrombi of the vessel wall
• Small to medium sized vessels
• Involves all layers of the vessels
• Integrity of the vessel wall structure is
maintained including internal elastic lamina
• Later on spreads to the adjoining nerve and
vein
Pathogenesis of Buerger’s Disease
• Induced by an unknown agent from smoking
& tobacco chewing, nicotine patch
• Rickettsia infection
• Increased antiendothelial antibodies
• Impaired relaxation of the peripheral vessels
• HLA-A9, HLA-54, HLA-B5
• Increased sensitivity to type 1 & type III
collagen
Assessment
• Disappearing pulse: decreased pulse pressure
on exercise: pulse disappears on exercise
• Allen’s test: positive in young patient with foot
ulceration: Buerger’s Disease
• doppler: harmless, defines level
Investigations
• ECG: rule out embolic phenomenon
• Angio(Arterio)graphy: (convntional/ MR/ CT)
– Buerger’s (TAO): corkscrew collaterals, tree root/ spider leg appearance
– Atherosclerosis (ASO): level of obstruction
Other investigations
General
• FBC
• U/E
• Lipid profile
• ECG
• ESR
• CRP
• Homocystine
• PT/ aPTT/ INR, Protein C/S/ Factor
V leiden, Antithrombin III/ Lupus
anticoag
• Carotid duplex
Buerger’s Disease specific treatments
• Prostaglandins (limaprost/iloprost) : antiplatelets &
vasodilators
– Increase cutaneous & muscular blood supply
• Bosentan: endothelin antagonist
• Epidural anaesthesia
• Hyperbaric Oxygen therapy
• Genetic therapy by VEGF gene intramuscular transfer
• Stem cell & VEGF injections intramuscularly
• Debridement
Buerger’s: Surgeries

• Lumbar Sympathectomy- • Chemical Sympathectomy


open or endoscopic,
remove 2nd -4th lumbar
sympathetic ganglia
• Amputation
Atherosclerosis: specific T/T
Endovascular Surgical
• Self expandable metallic • Endarterectomy
stents • Bypass:
• Balloon expandable stents – Aortobifemoral
– Axillobifemoral
– Femorofemoral
– Obturator bypass
– Axillopopliteal
– Thoracofemoral
– Infrainguinal
REFERENCES
• Beard J D Gaines P A. Management of the acutely
ischaemic leg. Curr Pract Surg 1995; 7: 123-130.
• Beattie D K Davies A H. Management of the acutely
ischaemic limb. Br J Hosp Med 1996; 55: 204-208.
• Earnshaw J J. Thrombolysis in acute limb ischaemia.
Ann R Coll Surg Eng 1994; 76: 216-222.
• Golledge J Galland R B. Lower limb intra-arterial
thrombolysis. Postgrad Med J 1995; 71: 146-150.
REFERENCES
• Carroll PR, McAninch JW, Klosterman P, Greenblatt M
(1984) Renovascular trauma: risk assessment, surgical
management, and outcome. J Trauma 30:547
• Courcy PA, Brotman S, Oster-Grantie ML, et al. (1984)
Superior mesenteric artery and vein injuries from blunt
abdominal trauma. J Trauma 24:843
• Dajee H, Richardson IW, Iype MO (1979) Seatbelt aorta:
acute dissection and thrombosis of the abdominal aorta.
Surgery 85:263
• Feliciano DV (1998) Approach to major abdominal vascular
injury. J Vasc Surg 7:730

You might also like